{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Bridging the Research Gap: Genetically Modified Pigs in Cancer Trials with Jessicca Rege","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/925e5e6e\"></iframe>","width":"100%","height":180,"duration":3233,"description":"In this episode of The Healthy Enterprise, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.Chapters:00:00 Introduction to Jessicca Rege and Sus Clinicals07:30 The Oncopig Model: Revolutionizing Cancer Research18:04 The Journey of a Mutant Pig Farmer24:51 AI in Cancer Research and Future Directions27:14 Introduction to OncoScope AI and Leadership Roles28:36 Disruptive Leadership and Questioning the Status Quo30:45 Navigating Imposter Syndrome as a CEO32:42 The Challenges of Being a Female Leader35:41 Cultivating Future Female Leaders39:03 Steering Growth at Sus Clinicals41:33 Innovative Approaches in Large Animal Research45:34 Future Outlook and Goals for Sus Clinicals49:25 Advice for Aspiring LeadersGuest Information:Guest's Name: Jessicca RegeGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jessiccarege/Company / Affiliation: Sus Clinicals https://susclinicals.com/Guest's Bio: Jessicca Rege is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}